STF-083010

CAS No. 307543-71-1

STF-083010( STF-083010 | STF 083010 | STF083010, IRE1 Inhibitor I )

Catalog No. M18401 CAS No. 307543-71-1

STF-083010 is a selective inhibitor of the IRE1α endonuclease.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 50 In Stock
5MG 45 In Stock
10MG 69 In Stock
25MG 117 In Stock
50MG 200 In Stock
100MG 360 In Stock
200MG 544 In Stock
500MG 793 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    STF-083010
  • Note
    Research use only, not for human use.
  • Brief Description
    STF-083010 is a selective inhibitor of the IRE1α endonuclease.
  • Description
    STF-083010, also known as IRE1 Inhibitor I, is an inhibitor of the IRE1/XBP1 pathway.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    STF-083010 | STF 083010 | STF083010, IRE1 Inhibitor I
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    IRE1α
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    307543-71-1
  • Formula Weight
    317.38
  • Molecular Formula
    C15H11NO3S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 100 mg/mL 315.08 mM; H2O : < 0.1 mg/mL
  • SMILES
    c1ccc2c(c1)C=CC(=O)/C/2=C\NS(=O)(=O)c1cccs1
  • Chemical Name
    (E)-N-((2-hydroxynaphthalen-1-yl)methylene)thiophene-2-sulfonamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Papandreou l, et al. Blood. 2011, 117(4), 1311-1314.
molnova catalog
related products
  • (E)-SI-2

    (E)-SI-2 is a potent small-molecule inhibitor of steroid receptor coactivator-3 (SRC-3 or AIB1) that can selectively inhibit the intrinsic transcriptional activities of SRC-3, also inhibits SRC-1 and SRC-2.

  • Chrysophanol trigluc...

    Chrysophanol triglucoside is an anthraquinone isolated from Cassia obtusifolia, inhibits protein tyrosine phosphatases 1B (PTP1B) and α-glucosidase with IC50s of 80.17 and 197.06 μM, respectively. Chrysophanol triglucoside has the potential for diabetes research.

  • Nimustine Hydrochlor...

    Nimustine has been used in trials studying the treatment of Glioblastoma.